Posted by
Chemoimmunotherapy Regimen Approved to Treat DLBCL

Chemoimmunotherapy Regimen Approved to Treat DLBCL

Latest Cancer News TUESDAY, June 11, 2019 (HealthDay News) — Polivy (polatuzumab vedotin-piiq), a novel antibody-drug conjugate, received approval to treat patients with diffuse large B-cell lymphoma (DLBCL) in combination with bendamustine and rituximab, the U.S. Food and Drug Administration announced today. The combination was approved for patients whose disease has progressed or returned after […]

Posted by
Ibrance (palbociclib)

Ibrance (palbociclib)

What drugs interact with Ibrance? Palbociclib is primarily metabolized by CYP3A and sulfotransferase (SULT) enzyme SULT2A1. In vivo, palbociclib is a time-dependent inhibitor of CYP3A. Effect of CYP3A Inhibitors Coadministration of a strong CYP3A inhibitor (itraconazole) increased the plasma exposure of palbociclib in healthy subjects by 87%. Avoid concomitant use of strong CYP3A inhibitors (e.g., […]

Posted by
Triple-Negative Breast Cancer

Triple-Negative Breast Cancer

Triple-Negative Breast Cancer Breast Lump There are many causes of breast lumps. Some of these causes are harmless, while others can be painful and/or dangerous. Causes of breast lumps include infections, injuries, non-cancerous growths, and cancer. Breast cancer is the second leading cause of cancer-related deaths in women in the United States. Currently, death rates […]

Posted by
Cancer: New compound boosts chemo, prevents treatment resistance

Cancer: New compound boosts chemo, prevents treatment resistance

Researchers may have found a way to stop cancer cells from defending themselves against chemotherapy. In a new mouse study, blocking a DNA repair pathway prevented cancer cells from surviving or becoming resistant to treatment. Researchers screened 10,000 drugs and found a compound that boosts cisplatin. Graham Walker, the American Cancer Society Research Professor of […]

Posted by
New report shows overall cancer mortality on the decline

New report shows overall cancer mortality on the decline

Overall mortality rates continue to decline, according to the most recent Annual Report to the Nation on the Status of Cancer. Cancer mortality has declined, but certain demographic groups are more at risk than others. This report, which appears in the Journal of the National Cancer Institute, was a joint effort among the National Cancer […]

Posted by
Guard Your Skin Against the Summer Sun

Guard Your Skin Against the Summer Sun

Latest Cancer News THURSDAY, June 6, 2019 (HealthDay News) — Whether you’re at the beach, the park or a pool this summer, be sure to protect your skin from the sun’s damaging rays. Skin cancer is the most common type of cancer in the United States, and most skin cancers are caused by too much […]

Posted by
Uterine Cancer

Uterine Cancer

There are different types of treatment for patients with endometrial cancer. Different types of treatment are available for patients with endometrial cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information […]

Posted by
Few Prostate Cancer Patients Are Getting Checkups They Need

Few Prostate Cancer Patients Are Getting Checkups They Need

Latest Cancer News WEDNESDAY, June 5, 2019 (HealthDay News) — While men with early-stage prostate cancer can delay treatment, few follow guidelines for monitoring their condition, researchers report. In fact, their study of nearly 350 men from North Carolina found that only 15% who chose what’s known as active surveillance followed the recommended guidelines. “Active […]